Coston McIsaac & Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$359K Buy
1,682
+1
+0.1% +$224 0.08% 102
2025
Q4
$287K Hold
1,681
0.07% 116
2025
Q3
$225K Buy
1,681
+1
+0.1% +$106 0.05% 138
2025
Q2
$163K Buy
1,680
+2
+0.1% +$159 0.04% 158
2025
Q1
$122K Buy
1,678
+1
+0.1% +$79 0.04% 166
2024
Q4
$121K Buy
1,677
+7
+0.4% +$531 0.04% 169
2024
Q3
$136 Hold
1,670
0.04% 150
2024
Q2
$178K Hold
1,670
0.06% 130
2024
Q1
$162K Hold
1,670
0.05% 135
2023
Q4
$131K Hold
1,670
0.05% 147
2023
Q3
$104K Hold
1,670
0.04% 160
2023
Q2
$107K Buy
1,670
+10
+0.6% +$564 0.04% 164
2023
Q1
$88K Hold
1,660
0.03% 185
2022
Q4
$70 Hold
1,660
0.03% 221
2022
Q3
$60K Hold
1,660
0.03% 196
2022
Q2
$71K Buy
+1,660
New +$79K 0.04% 113

Other funds holding LRCX

Coston McIsaac & Partners's LRCX Position: Q1 2026 in Review

Coston McIsaac & Partners increased its Lam Research (LRCX) stake by 0.06% in Q1 2026, buying an estimated $224 and bringing the position to 1,682 shares worth $359K. The position accounts for 0.08% of the portfolio, ranked #102.

Coston McIsaac & Partners first reported a position in LRCX in Q2 2022 and has held it in 16 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Coston McIsaac & Partners held 1,682 shares of Lam Research worth $359K as of Q1 2026.
  • Coston McIsaac & Partners bought 1 Lam Research share in Q1 2026, an estimated $224.
  • Lam Research made up 0.08% of Coston McIsaac & Partners's portfolio in Q1 2026, its #102 holding.
  • Coston McIsaac & Partners first reported a position in Lam Research in Q2 2022 and has held it in 16 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.